• Also late yesterday, Boston Scientific (BSX) said the U.S. Food and Drug Administration has approved its latest drug-eluting stent, the Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System.

    FORBES: Health Care News: Merck, Boston Scientific

  • The new Abbott also sells medical devices such as artery-clearing drug-eluting Xience stent or its absorbable stent known as Absorb and diagnostic tests used in laboratories and hospitals such as its Architect platform.

    FORBES: Move up http://i.forbesimg.com t Move down

  • In the vascular business, the company is developing a next-generation Drug Eluting Stent, XIENCE Xpedition, which is expected to launch in Europe this year and in the U.S. in 2013.

    FORBES: Abbott Labs Snapshot As AbbVie Begins Trading

  • Moderate growth is expected from vascular and diagnostics division (excluding to certain royalty and supply arrangement revenues and currency impact), after the company launched various products including its next-generation Drug Eluting Stent XIENCE Xpedition and XIENCE PRIME in different parts of the world.

    FORBES: Abbott Earnings Preview: What We Are Watching

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定